|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.100 CAD | +37.84% |
|
+34.56% | +127.68% |
| Capitalization | 2.86B 2.43B 2.27B 2.14B 3.94B 259B 4.3B 26.54B 10.3B 122B 10.72B 10.5B 445B | P/E ratio 2025 * |
-12.5x | P/E ratio 2026 * | -19.9x |
|---|---|---|---|---|---|
| Enterprise value | 3.27B 2.79B 2.6B 2.45B 4.51B 296B 4.93B 30.39B 11.79B 140B 12.28B 12.02B 510B | EV / Sales 2025 * |
2.57x | EV / Sales 2026 * | 2.33x |
| Free-Float |
60.4% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Curaleaf Holdings, Inc.
| 1 day | +37.84% | ||
| 1 week | +34.56% | ||
| Current month | +57.41% | ||
| 1 month | +41.27% | ||
| 3 months | +53.15% | ||
| 6 months | +367.89% | ||
| Current year | +127.68% |
| 1 week | 3.45 |  | 5.55 |
| 1 month | 2.65 | | 5.55 |
| Current year | 0.99 | | 5.55 |
| 1 year | 0.99 | | 5.55 |
| 3 years | 0.99 | | 8.73 |
| 5 years | 0.99 | | 23.3 |
| 10 years | 0.99 | | 23.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Boris Jordan
CEO | Chief Executive Officer | 59 | 2024-08-15 |
Edward Kremer
DFI | Director of Finance/CFO | - | 2022-08-07 |
Jessie Kater
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Boris Jordan
CHM | Chairman | 59 | 2014-12-31 |
Joseph Lusardi
BRD | Director/Board Member | 51 | 2016-02-29 |
Karl Johansson
BRD | Director/Board Member | 75 | 2018-07-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +37.84% | +34.56% | +127.68% | -25.00% | 2.86B | |
| +64.45% | +61.52% | +99.12% | +7.77% | 1.66B | |
| +28.36% | +38.71% | +120.51% | +117.72% | 666M | |
| Average | +43.55% | +44.93% | +115.77% | +33.50% | 1.73B | |
| Weighted average by Cap. | +45.14% | +43.72% | +117.62% | +3.83% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.27B 1.08B 1.01B 952M 1.75B 115B 1.91B 11.81B 4.58B 54.28B 4.77B 4.67B 198B | 1.35B 1.15B 1.08B 1.01B 1.87B 123B 2.04B 12.58B 4.88B 57.82B 5.08B 4.97B 211B |
| Net income | -221M -188M -176M -165M -304M -19.99B -332M -2.05B -795M -9.42B -828M -811M -34.38B | -147M -125M -117M -110M -203M -13.31B -221M -1.37B -529M -6.27B -551M -540M -22.89B |
| Net Debt | 414M 353M 329M 310M 571M 37.5B 623M 3.85B 1.49B 17.68B 1.55B 1.52B 64.49B | 303M 258M 241M 227M 418M 27.44B 456M 2.81B 1.09B 12.94B 1.14B 1.11B 47.2B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-12 | 5.100 $ | +37.84% | 7,230,006 |
| 25-12-11 | 3.700 $ | +0.54% | 290,703 |
| 25-12-10 | 3.680 $ | -2.13% | 221,150 |
| 25-12-09 | 3.760 $ | +6.21% | 359,071 |
| 25-12-08 | 3.540 $ | -6.60% | 567,856 |
Delayed Quote Toronto S.E., December 12, 2025 at 04:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CURA Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition